RxDoctor Payments Data

Lori Love

Nurse Practitioner · Thomasville, NCNPI 1376056788

Payments from drug & device makers

$4,837in general payments, 2019–2025

Across 140 payments — averaging $34.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Medtronic$366
  • Nevro Corp.$311
  • SPR Therapeutics, Inc$199
  • MML US, Inc.$147
  • Collegium Pharmaceutical, Inc.$121
  • plus $276 from 8 others

What the payments were for

  • Travel & lodging$1,28627%
  • Food & beverage$3,55173%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,837 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$29,504
Medicare patients
103
Services billed
324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl86$107,660
Xtampza ErOxycodone Myristate118$68,533
NucyntaTapentadol Hcl33$19,120
Gabapentin514$8,395
Buprenorphine36$7,958
MovantikNaloxegol Oxalate19$7,737
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen216$5,672
Pregabalin249$5,449
Lidocaine38$4,905
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen160$4,465
Tizanidine Hcl307$3,907
Methocarbamol184$3,150
Diclofenac Sodium69$1,684
Cyclobenzaprine Hcl155$1,513
Morphine Sulfate ErMorphine Sulfate49$1,432

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er, Nucynta$121$195,313237 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Thomasville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →